Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02516514
Other study ID # 10-033
Secondary ID
Status Completed
Phase N/A
First received July 28, 2015
Last updated August 4, 2015
Start date December 2010
Est. completion date December 2012

Study information

Verified date August 2015
Source University Hospital, Caen
Contact n/a
Is FDA regulated No
Health authority France: Ethics Committee
Study type Interventional

Clinical Trial Summary

Current recommendations for the diagnosis of bacteremia based on the embodiment February-March blood cultures separated by a minimum interval of 30 minutes. Each blood culture comprises seeding a pair of aerobic and anaerobic vials inoculated each with 5 to 10 ml of blood. The sensitivity and specificity of this technique depends essentially on the amount of blood removed since there is a direct relationship between the volume of blood inoculated into each flask and the efficiency of the technique. A preliminary study conducted at the University Hospital of Caen found that 14-30% of patients depending on the services had received only one blood culture. In addition, at least four blood cultures in 24 hours were taken for 10 to 20% of patients. The practice of a single blood culture reduces the sensitivity of the analysis due to insufficient total amount of blood collected. The practice of too many blood cultures increases the risk of false positive (presence of contaminating bacteria), generates extra work for healthcare personnel (and laboratory) and represents a significant cost for an unproven benefit.

The investigators propose to evaluate a single blood culture sampling technique with seeding 4 vials (2 aerobic and anaerobic 2).


Description:

Blood cultures will be collected from patients admitted with on of the following signs: fever (≥38.5°C), hypothermia (≤36°C), chills or shock. For the first blood culture, 40 mL of blood will be obtained aseptically by a single phlebotomy and equally distributed into two BacT/Alert FA aerobic bottles and two BacT/Alert FN anaerobic bottles (bioMérieux, La-Balme-les-Grottes, France). The four bottles will be labelled from one to four in the following order: aerobic-anaerobic-aerobic-anaerobic. Within the next 24 h, one to three other 20-mL blood cultures consisting of a single pair of aerobic and anaerobic bottles will have to be performed, spaced by a minimum of 30 minutes. Bottles will be incubated for 5 days or until positivity reported by the BacT/Alert 3D instrument.


Recruitment information / eligibility

Status Completed
Enrollment 302
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient who is at least 18 years

- Patients admitted to an emergency department of a three CHU Caen, Lille, Rouen

- Patient with clinical justifying the realization of blood cultures (as good practice recommendations)

- Patients who received information about the study or if his legal representatives or his close entourage

- Patient not objecting to the venipuncture

Exclusion Criteria:

- Patient who direct venipuncture is impossible

- Patient refusing venipuncture

- Patient aged under 18

- Patient with impaired vigilance and not accompanied by a family member or a trusted person may receive clear information protocol

- Vulnerable Patient and not accompanied by a family member or a trusted person may receive clear information protocol

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Procedure:
Single-sampling strategy vs multi-sampling strategy for the diagnosis of bacteremia
Comparison between two strategies of blood culture (single-sampling strategy and multi-sampling strategy) for the diagnosis of bacteremia

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Caen

References & Publications (5)

Arendrup M, Jensen IP, Justesen T. Diagnosing bacteremia at a Danish hospital using one early large blood volume for culture. Scand J Infect Dis. 1996;28(6):609-14. — View Citation

Cockerill FR 3rd, Wilson JW, Vetter EA, Goodman KM, Torgerson CA, Harmsen WS, Schleck CD, Ilstrup DM, Washington JA 2nd, Wilson WR. Optimal testing parameters for blood cultures. Clin Infect Dis. 2004 Jun 15;38(12):1724-30. Epub 2004 May 25. — View Citation

Lamy B, Roy P, Carret G, Flandrois JP, Delignette-Muller ML. What is the relevance of obtaining multiple blood samples for culture? A comprehensive model to optimize the strategy for diagnosing bacteremia. Clin Infect Dis. 2002 Oct 1;35(7):842-50. Epub 2002 Sep 10. — View Citation

Lee A, Mirrett S, Reller LB, Weinstein MP. Detection of bloodstream infections in adults: how many blood cultures are needed? J Clin Microbiol. 2007 Nov;45(11):3546-8. Epub 2007 Sep 19. — View Citation

Li J, Plorde JJ, Carlson LG. Effects of volume and periodicity on blood cultures. J Clin Microbiol. 1994 Nov;32(11):2829-31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of pathogens identified by each strategy baseline No
Secondary Proportion of blood cultures contaminated in each strategy baseline No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Completed NCT02400268 - Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae Phase 3
Recruiting NCT04070820 - Combination Treatment for Enterococcus Faecalis Bacteriemia Multicenter, Observational Study"
Completed NCT03147807 - BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICU N/A
Completed NCT05411315 - Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment N/A
Enrolling by invitation NCT05880069 - Clinical Outcomes in Patients With Infection by Resistant Microorganism
Terminated NCT04250168 - Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response
Terminated NCT04876430 - Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems Phase 2/Phase 3
Completed NCT03255759 - Actionable Results: Bloodstream Infection Molecular Assay Evaluation N/A
Active, not recruiting NCT03744728 - Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures N/A
Terminated NCT00680459 - Ethanol Locks for the Treatment of Central Venous Line Infections Phase 3
Recruiting NCT04839653 - Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant Bacteria N/A
Recruiting NCT03896893 - Neonatal Bacterial Colonization Study N/A
Completed NCT05277350 - A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects Phase 1
Recruiting NCT00843804 - Surveillance for Nosocomial Infections in Pediatric Cancer Patients N/A
Completed NCT00467272 - Catheter Related - Gram Positive Bloodstream Infections Phase 2
Recruiting NCT04658017 - GARNET™ Filter (GARNET Device) IDE Used in Chronic Hemodialysis Patients With a Bloodstream Infection N/A
Completed NCT04710212 - Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies
Not yet recruiting NCT06271031 - Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection
Not yet recruiting NCT03991793 - Granzyme A in Patients With E. Coli Bacteremic Urinary Tract Infections